Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for neuropathic pain in centrally sensitized patients treated with duloxetine after total knee arthroplasty
KCT0007301Phase 4Not yet recruiting
- Sponsor
- Seoul St. Mary's Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pregabalin in Neuralgia, Central sensitization (CS), knee osteoarthritis (OA), sponsored by Seoul St. Mary's Hospital. Planned start May 2022; status: not yet recruiting.
02
Drugs
pregabalin
03
Conditions
NeuralgiaCentral sensitization (CS)knee osteoarthritis (OA)
Beyond the preview
Go deeper on KCT0007301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007301.